-
Innovation Ranking
NewInnovation Ranking – ION Geophysical Corp
ION Geophysical Corp (ION) is a provider of seismic solutions. It offers geoscience products, services and solutions to the global oil and gas industry. The company acquires, processes and interprets data from seismic surveys in regional data programs, which become part of the multi-client data library. Its product portfolio comprises land and marine seismic data acquisition equipment; seismic data libraries; navigation, command and control, and data management software products; seismic data processing and reservoir imaging services; and planning services for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ION-547 in Thrombosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ION-547 in Thrombosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ION-547 in Thrombosis Drug Details: ION-547 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ION-859 in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ION-859 in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ION-859 in Parkinson's Disease Drug Details: ION-859 (IONISBIIB-7Rx) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ION-464 in Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ION-464 in Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ION-464 in Multiple System...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ION-717 in Neurodegenerative Diseases
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ION-717 in Neurodegenerative Diseases report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ION-717 in Neurodegenerative Diseases Drug Details: ION-716 is under development for the...
-
Sector Analysis
NewPost-Operative Pain (POP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Post-Operative Pain (POP) Marketed and Pipeline Drugs Report Overview Post-operative pain (POP) is considered a form of acute pain due to surgical trauma with an inflammatory reaction and initiation of an afferent neuronal barrage. There could also be some generalized body pain before the operation with aggravation after the operation. This type of operation often needs complete or partial anesthesia. Disturbances in the channels and collaterals or the internal organs may be the cause. Key Mechanisms of Action (Marketed) ·      ...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ION-537 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ION-537 in Solid Tumor Drug Details: ION-537 is under development for the treatment of solid...
-
Product Insights
Zhongna Energy – Guangde Sodium-Ion Battery Manufacturing Base – Anhui
The Zhongna Energy – Guangde Sodium-Ion Battery Manufacturing Base – Anhui project involves the construction of a sodium-ion battery manufacturing base in Guangde, Anhui, China. Equip yourself with the essential tools needed to make informed and profitable decisions with our Zhongna Energy – Guangde Sodium-Ion Battery Manufacturing Base – Anhui report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ION-537 in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ION-537 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Drug Details: ION-537 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BHV-7000 in Generalized Seizures
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BHV-7000 in Generalized Seizures report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BHV-7000 in Generalized Seizures Drug Details: BHV-7000 is under development for...